Tag: apollo

16 UK biotech companies you should know about

The UK is home to several biotech hubs, including the famous ‘golden triangle’, made up of Oxford, Cambridge, and London. In fact, after a $700 million surge in funding in the third quarter of 2023, the UK biotech scene is now one of the most vibrant in Europe, laying the…

Continue Reading 16 UK biotech companies you should know about

Altered quorum sensing and physiology of Staphylococcus aureus during spaceflight detected by multi-omics data analysis

CDC. (ed CDC) (U.S. Department of Health and Human Services, CDC; 2019, Atlanta, GA, 2019). Krismer, B., Weidenmaier, C., Zipperer, A. & Peschel, A. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 15, 675–687 (2017). Article  CAS  PubMed  Google Scholar  Somerville, G….

Continue Reading Altered quorum sensing and physiology of Staphylococcus aureus during spaceflight detected by multi-omics data analysis

Nifty Rebounds To Close On New High As Blue chips Trim Losses FMCG Trade Highest – BW Businessworld

The Indian stock market changed its route to return into green territory as blue-chips recovered after early losses during the session. The benchmark indices, Nifty and Sensex conclude on a new-high on Tuesday after snapping its muted streak. The National stock exchange (NSE) Nifty 50 index closed at 21,453 or…

Continue Reading Nifty Rebounds To Close On New High As Blue chips Trim Losses FMCG Trade Highest – BW Businessworld

Blackstone aims to trim PGP Glass stake; KKR eyes 50% stake in Cotiviti

S&P Global Market Intelligence presents In Play Today, a periodic summary of potential private equity deal activity, including rumored transactions. This summary is based on information obtained on a best-efforts basis and may not be inclusive of all potential deal activity. – TPG Inc., Peak XV Partners and Matrix Partners…

Continue Reading Blackstone aims to trim PGP Glass stake; KKR eyes 50% stake in Cotiviti

Marker Therapeutics (MRKR) Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse

Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today reported a clinical update on the APOLLO study. The Phase 1 APOLLO study is investigating MT-601, a multi-tumor associated antigen (multiTAA)-specific T cell…

Continue Reading Marker Therapeutics (MRKR) Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse

Dispersal from the Qinghai-Tibet plateau by a high-altitude butterfly is associated with rapid expansion and reorganization of its genome

Zachos, J., Pagani, H., Sloan, L., Thomas, E. & Billups, K. Trends, rhythms, and aberrations in global climate 65 Ma to present. Science 292, 686–693 (2001). Article  ADS  CAS  PubMed  Google Scholar  Favre, A. et al. The role of the uplift of the Qinghai-Tibetan Plateau for the evolution of Tibetan…

Continue Reading Dispersal from the Qinghai-Tibet plateau by a high-altitude butterfly is associated with rapid expansion and reorganization of its genome

A naturally occurring polyacetylene isolated from carrots promotes health and delays signatures of aging

Cell culture conditions Unless otherwise stated, cells were cultured with DMEM (Sigma Aldrich; #D6429) and 4.5 g/l glucose, phenol red, 10% FBS, and 1% penicillin/streptomycin with pH 7.4 and were incubated at 37 °C, 5% CO2, and 95% relative humidity. Wild-type HepG2 (#300198), HEK293 (#300192), and MCF-7 (#300273) were derived from CLS…

Continue Reading A naturally occurring polyacetylene isolated from carrots promotes health and delays signatures of aging

A chromosome-level genome assembly for the Silkie chicken resolves complete sequences for key chicken metabolic, reproductive, and immunity genes

Friedman-Einat, M. & Seroussi, E. Avian leptin: bird’s-eye view of the evolution of vertebrate energy-balance control. Trends Endocrinol. Metab. 30, 819–832 (2019). Article  CAS  PubMed  Google Scholar  International Chicken Genome Sequencing C. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 432, 695–716 (2004)….

Continue Reading A chromosome-level genome assembly for the Silkie chicken resolves complete sequences for key chicken metabolic, reproductive, and immunity genes

Scientist II, Bioinformatics, Machine Learning Job

Job Description Tome Biosciences is the programmable gene insertion company. Using CRISPR, our technologies allow us to insert any genetic sequence of any size at any location into any genome. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and genome engineering. Tome is…

Continue Reading Scientist II, Bioinformatics, Machine Learning Job

Record Store Day Guide To 14 Unreleased & Reissued Jazz Recordings: Brubeck, Evans, Jamal & More

Rather than provide our usual detailed reviews of these never-before-released and/or reissued jazz recordings, we will instead provide a summary of each in alphabetical order by artist. While we see some of the usual suspects such as Bill Evans, Wes Montgomery, Charles Mingus, and Oscar Peterson, we also see Les…

Continue Reading Record Store Day Guide To 14 Unreleased & Reissued Jazz Recordings: Brubeck, Evans, Jamal & More

State Secretary Addresses AI Fringe in Speech

Good morning. A big thank you to Milltown Partners, too, and everyone involved in the AI Fringe, for putting on such an exciting range of events…of course, not just here in London but right across the UK – in Oxford, Cambridge, Bristol, Edinburgh and beyond. AI has the potential to…

Continue Reading State Secretary Addresses AI Fringe in Speech

Vutrisiran Shows Benefit Across Baseline Severities in Phase 3 HELIOS-A Study

In a new post-hoc analysis of the phase 3 HELIOS-A study (NCT03759379) assessing vutrisiran (Amvuttra; Alnylam), an FDA-approved RNA interference therapeutic, the therapy demonstrated benefit in key measures, compared with external placebo, across all baseline polyneuropathy severities among patients with hereditary transthyretin-mediated (hATTR) amyloidosis. These results suggest patients who initiate…

Continue Reading Vutrisiran Shows Benefit Across Baseline Severities in Phase 3 HELIOS-A Study

Alnylam Pharmaceuticals, Inc. Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine -October 25, 2023 at 05:19 pm EDT

Alnylam Pharmaceuticals, Inc. announced that results from the APOLLO-B Phase 3 study of investigational patisiran in patients with the cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis were published online in the New England Journal of Medicine (NEJM). The data reported in the APOLLO-B Phase 3 study publication demonstrate that patisiran, an RNAi therapeutic targeting transthyretin (TTR), preserved…

Continue Reading Alnylam Pharmaceuticals, Inc. Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine -October 25, 2023 at 05:19 pm EDT

Alnylam Pharma (ALNY) Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that results from the APOLLO-B Phase 3 study of investigational patisiran in patients with the cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis were published online in the New England Journal of Medicine (NEJM). The data reported in the APOLLO-B Phase…

Continue Reading Alnylam Pharma (ALNY) Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran

Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine -October 25, 2023 at 05:20 pm EDT

– Treatment with an RNAi Therapeutic Preserved Functional Capacity and Health Status and Quality of Life Compared with Placebo at 12 Months – – Patisiran Demonstrated an Encouraging Safety and Tolerability Profile in Patients with the Cardiomyopathy of ATTR Amyloidosis – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…

Continue Reading Alnylam Announces Publication of Results from APOLLO-B Phase 3 Study of Patisiran in Patients with the Cardiomyopathy of ATTR Amyloidosis in the New England Journal of Medicine -October 25, 2023 at 05:20 pm EDT

2023-10-25 | NDAQ:ALNY | Press Release

– Treatment with an RNAi Therapeutic Preserved Functional Capacity and Health Status and Quality of Life Compared with Placebo at 12 Months – – Patisiran Demonstrated an Encouraging Safety and Tolerability Profile in Patients with the Cardiomyopathy of ATTR Amyloidosis – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…

Continue Reading 2023-10-25 | NDAQ:ALNY | Press Release

Companies that had their IPO in 2016

Hostess Brands, the iconic American company behind beloved snacks like Twinkies and Ding Dongs, made a significant comeback with its entry into the public markets in November 2016. This move was particularly notable given the company’s tumultuous history, including its bankruptcy in 2012 and subsequent acquisition by Apollo Global Management…

Continue Reading Companies that had their IPO in 2016

Rama Melange Residences Hinjewadi Phase-3 – Without Brokerage Fully furnished 3 BHK Flat for Sale in Rama Melange Residences , Pune for Rs. 10,000,000

Description Livability Score is a measure of proximity of the property to essential facilities and amenities on a scale of 0 to 10 5.2 Transit Score is a measure of how well a property is served by public transit on a scale from 0 to 10 0.5 Powered By: Smart…

Continue Reading Rama Melange Residences Hinjewadi Phase-3 – Without Brokerage Fully furnished 3 BHK Flat for Sale in Rama Melange Residences , Pune for Rs. 10,000,000

Alnylam Pharmaceuticals: A Good Buy Ahead Of Phase 3 Data For Vutrisiran (NASDAQ:ALNY)

Cardiac amyloidosis OGphoto Alnylam logo We rate Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) a Buy on the dip after the complete response letter, CRL for Patisiran. The investment thesis is based on the high probability of success for Vutrisiran, the company’s next-generation inverse RNA or RNAi candidate, in treating cardiac amyloidosis in…

Continue Reading Alnylam Pharmaceuticals: A Good Buy Ahead Of Phase 3 Data For Vutrisiran (NASDAQ:ALNY)

FDA Denies Approval for Patisiran in ATTR Cardiomyopathy

The US Food and Drug Administration (FDA) has declined to approve the RNA interference (RNAi) therapeutic agent patisiran (Onpattro, Alnylam Pharmaceuticals) for treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy, the company has announced. ATTR amyloidosis is an underdiagnosed, rapidly progressive, debilitating, fatal disease caused by misfolded TTR proteins, which accumulate…

Continue Reading FDA Denies Approval for Patisiran in ATTR Cardiomyopathy

The biggest private biotech investments in September 2023

The companies Generate Biomedicines, Apollo Therapeutics and Nimbus Therapeutics bagged the biggest biotech investments in September 2023. Around the world, drug discovery and oncology players attracted the biggest funding rounds. As we made our way into autumn in the Northern Hemisphere, September 2023 saw some big funding rounds take place…

Continue Reading The biggest private biotech investments in September 2023

Shuttle Blankets and Space Burials

A Shuttle emergency you may never have heard of, sending your DNA into space, and a scientist who gets to study the newly-returned sample from asteroid Bennu. Sue Nelson and Richard Hollingham meet Natural History Museum’s meteorites curator, Natasha Vasiliki Almeida, and talk to the founder of Celestis, Charles Chafer,…

Continue Reading Shuttle Blankets and Space Burials

Ralph Cram – File 770

(1) WAYS IN WHICH PRATCHETT IS STILL WITH US. Sam Jordison discusses “Pratchett power: from lost stories to new adaptations, how the late Discworld author lives on” in the Guardian. “Of all the dead authors in the world, Terry Pratchett is the most alive,” said John Lloyd at the author’s memorial in…

Continue Reading Ralph Cram – File 770

Genome-wide probing of eukaryotic nascent RNA structure elucidates cotranscriptional folding and its antimutagenic effect

Yeast strain and growth conditions S. cerevisiae strain BY4741 was grown in YPD media at 30 °C. Saturated cultures were diluted into 300 ml YPD medium with an optical density at 660 nm (OD660) of approximately 0.1 and then grown at 30°C with shaking at 250 rpm until mid-log phase with an OD660 of…

Continue Reading Genome-wide probing of eukaryotic nascent RNA structure elucidates cotranscriptional folding and its antimutagenic effect

Google Cloud is set to supercharge ONDC with generative AI to help non-tech-savvy sellers and buyers

Google Cloud declared to boost Open Network for Digital Commerce (ONDC) by leveraging the capabilities of generative AI during the Born Digital Summit in Bengaluru. They demonstrated the perks of this new capability, which is expected to benefit both sellers and buyers across India.    During the summit, the Managing Director…

Continue Reading Google Cloud is set to supercharge ONDC with generative AI to help non-tech-savvy sellers and buyers

Drug delivery systems for CRISPR-based genome editors

Li, Y., Glass, Z., Huang, M., Chen, Z. Y. & Xu, Q. Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications. Biomaterials 234, 119711 (2020). Article  CAS  PubMed  PubMed Central  Google Scholar  Dong, W. & Kantor, B. Lentiviral vectors for delivery of gene-editing systems based on CRISPR/Cas: current state and…

Continue Reading Drug delivery systems for CRISPR-based genome editors

Genetic Cancer Hereditary Cancer Mutations Susceptibility To Cancer Genetic Changes

Genetic Cancers: Welcome back to “The Science Of Health”, ABP Live’s health column. Last time, in the health column, we discussed the difference between small cell lung cancers and non-small cell lung cancers, and explained why small cell lung cancers are less common than non-small cell lung cancers, despite the…

Continue Reading Genetic Cancer Hereditary Cancer Mutations Susceptibility To Cancer Genetic Changes

Apollo taps cloud for telemedicine- The New Indian Express

By Express News Service CHENNAI: Apollo Hospitals is strengthening its telemedicine platform Apollo 24/7 by tapping the cloud, data intelligence, and artificial intelligence, among a host of other technologies. It is expanding its partnership with Google Cloud to develop various features including AI-based assistive technology for physicians. The partnership aims to…

Continue Reading Apollo taps cloud for telemedicine- The New Indian Express

Gmail users taking to AI in big way, says Kurien

More and more Gmail users are using AI-powered features to write their mails, Thomas Kurian, CEO, Google Cloud, said at the “Born Digital Summit” in Bengaluru on Wednesday. Since March, on an average, more than 50% of mails were written using generative models, he said, adding that 35% more mails…

Continue Reading Gmail users taking to AI in big way, says Kurien

More than 20 ecommerce firms adopt Google Cloud-ONDC’s Open Commerce solution, ET Retail

More than 20 ecommerce companies have adopted the Open Commerce solution of Google Cloud and ONDC, which the tech giant announced in June. This enables buyers, sellers and logistics service providers to onboard seamlessly onto the ONDC network. This will expand the ability for buyers and sellers, especially those in…

Continue Reading More than 20 ecommerce firms adopt Google Cloud-ONDC’s Open Commerce solution, ET Retail

Apollo Hospitals, Google Cloud to deliver gen AI-powered healthcare service

Appolo Hospitals on Wednesday (September 6) announced a new collaboration with Google Cloud to offer secured digital healthcare solutions to the masses in India. Due to the untimely Covid-19 outbreak in early 2020, governments in most countries including India, had to enforce lockdowns for almost one and a half years….

Continue Reading Apollo Hospitals, Google Cloud to deliver gen AI-powered healthcare service

We are introducing generational upgrades to our models every four months: Thomas Kurian

At Google Cloud’s Born Digital Summit held in Bengaluru on September 6, chief executive officer (CEO) Thomas Kurian said that the company introducing rapid upgrades and improvements to its artificial intelligence models to benefit customers and end users. “We are upgrading our models typically every two weeks so you get…

Continue Reading We are introducing generational upgrades to our models every four months: Thomas Kurian

Apollo Hospitals partners with Google Cloud

Apollo 24|7 teams worked with Google Cloud to build a Clinical Intelligence Engine (CIE) using Google Cloud’s Vertex AI and generative AI (gen AI) models Apollo Hospitals has announced an expanded partnership with Google Cloud to put healthcare in the hands of every Indian with Apollo’s digital platform, Apollo 24|7….

Continue Reading Apollo Hospitals partners with Google Cloud

Google Cloud set to supercharge ONDC with generative AI to help non-tech savvy sellers and buyers | Technology News

Open Network for Digital Commerce, commonly known as ONDC, is all set to gain generative AI capabilities. Google Cloud, at its Born Digital Summit in Bengaluru, demonstrated how this new capability will benefit both buyers and sellers in India. At the summit, Bikram Singh Bedi, Managing Director of Google Cloud…

Continue Reading Google Cloud set to supercharge ONDC with generative AI to help non-tech savvy sellers and buyers | Technology News

ApolloRNA main page

ApolloRNA main page Apollo for non protein coding RNA (ncRNA) identification ApolloRNA is an extension for ncRNA identification of the Apollo environment [1], a genome annotation viewer and editor. ApolloRNA is developed by the Biometry and Artificial Intelligence Laboratory of INRA Toulouse, France. Source code is available on the Forge…

Continue Reading ApolloRNA main page

Api source yaml file cannot be read if set with env variables

Versions: “@graphql-mesh/cli”: “^0.12.5”, “@graphql-mesh/config”: “^0.11.5”, “@graphql-mesh/openapi”: “^0.10.12”, “@graphql-mesh/runtime”: “^0.10.5”, “apollo-server”: “^2.18.2”, “dotenv”: “^8.2.0”, “graphql”: “^15.4.0”, “nodemon”: “^2.0.6”, “typescript”: “^4.1.2” “ts-node”: “^9.0.0”, “ts-node-dev”: “^1.0.0” Context: .meshrc.yaml file can be written with interpolation of environment variables so that one can keep IPs and other tokens in an .env file. This is particularly…

Continue Reading Api source yaml file cannot be read if set with env variables

India Gearing Up To Tackle Next Likely Pandemic After Coronavirus Antibiotic Resistance Influenza

Arboviruses, multi-drug resistant bacteria, Nipah, Marburg virus and the dreaded “Disease X” — one among them may cause the next Covid-like pandemic if the World Health Organization (WHO) is to be believed. A silent pandemic is also knocking on our doors — antibiotic resistance. As India celebrates its 77th Independence…

Continue Reading India Gearing Up To Tackle Next Likely Pandemic After Coronavirus Antibiotic Resistance Influenza

Google AlphaFold 2 | sciencesprings

From The Texas Advanced Computing Center At The University of Texas-Austin 8.3.23Jorge Salazar Deep learning methods have been used to augment existing energy-based physical models in ‘do novo’ or from-scratch computational protein design, resulting in a 10-fold increase in success rates verified in the lab for binding a designed protein…

Continue Reading Google AlphaFold 2 | sciencesprings

10 Plus AI Research Projects Everyone Should be Aware Of

AI has been making remarkable progress, revolutionizing numerous industries and capturing the imagination of experts and enthusiasts worldwide. Several notable research projects have emerged, showcasing the immense potential of artificial intelligence. By examining these projects, we can gain insights into the transformative impact of AI on various sectors. One prominent…

Continue Reading 10 Plus AI Research Projects Everyone Should be Aware Of

On-Demand DNA Synthesis in High Demand

The state of DNA synthesis is a bit like humanity’s journey to the moon—just because something has been achieved before doesn’t mean we should cease figuring out how to do it better.” That is how Harold P. de Vladar, CEO and founder of long-synthetic DNA service provider Ribbon Biolabs, sees…

Continue Reading On-Demand DNA Synthesis in High Demand

Apollo Alpha – Electroporation + Cryo + Thermo + Pulse Selection(id:11160301). Buy Korea Electroporation, Aesthetic Device, Beauty Device

Electroporation & Cryo & Thermo & +/- Pulse Selection  Professional Aesthetic Device What is Electroporation? Virtual Mesotherapy, classified by the FDA as an alternative to injections, is a system that allows the transdermal vehiculation of pharmaceutical and cosmetic products by means of electrofusion. Why Apollo Alpha? Stable & powerful temperature support…

Continue Reading Apollo Alpha – Electroporation + Cryo + Thermo + Pulse Selection(id:11160301). Buy Korea Electroporation, Aesthetic Device, Beauty Device

Circular RNA RSU1 promotes retinal vascular dysfunction by regulating miR-345-3p/TAZ

Patients and samples A total of 103 diabetes mellitus (type 2) patients were recruited according to the criteria from the American Diabetes Association30. Plasma samples were collected from blood of all the patients, and the patients were classified as diabetes mellitus patients without DR (n = 53) and diabetes mellitus patients with…

Continue Reading Circular RNA RSU1 promotes retinal vascular dysfunction by regulating miR-345-3p/TAZ

E-Learning Services Market Size and Share Analysis 2023

PRESS RELEASE Published July 10, 2023 The E-Learning Services Market Report 2023 provides a comprehensive analysis of the industry with a focus on business strategies, major trends, and regional segments. It also includes valuable insights into the value chain analysis of key players – Simplilearn, Age of Learning, Edmodo, edX,…

Continue Reading E-Learning Services Market Size and Share Analysis 2023

Unable to convert Swagger 2.0 to GraphQL

Not able to convert swagger openapi spec to GraphQL #64 Describe the bug oasgraph cli was not able to convert openapi spec to GraphQL To Reproduce oasgraph openapi.json Expected behavior GraphQL … Read more > Start with GraphQL today by converting your Swagger schema This will execute queries using the…

Continue Reading Unable to convert Swagger 2.0 to GraphQL

Some performance metrics may actually hurt what they measure

Who developed the theory of evolution? Who invented the telephone? What about the radio? Pretty obvious answers one would assume. Charles Darwin, Alexander Bell and Marconi respectively, right? Well, it’s not as straightforward as we might think. Both Charles Darwin and fellow naturalist Alfred Wallace independently arrived at the theory…

Continue Reading Some performance metrics may actually hurt what they measure

Direct-to-Consumer Genetic Testing Market Size is projected

New York, United States, June 12, 2023 (GLOBE NEWSWIRE) — The collective term for genetic tests marketed directly to consumers is “direct-to-consumer genetic testing” (DTC-GT). Without the assistance of a healthcare professional or health insurer, DTC-GT tests are sold directly to consumers. There are numerous ways to utilize genetic testing…

Continue Reading Direct-to-Consumer Genetic Testing Market Size is projected

Rising Genomics Investments by Pharmaceutical and Biotechnology Businesses to Fuel the Industry

DUBLIN, June 9, 2023 /PRNewswire/ — The “Gene Amplification Technologies Market Report 2023-2033” report has been added to  ResearchAndMarkets.com’s offering.  The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its…

Continue Reading Rising Genomics Investments by Pharmaceutical and Biotechnology Businesses to Fuel the Industry

Onpattro shows benefits for 1.5 years in ATTR cardiomyopathy trial | Therapy seen to slow down disability in people with ATTR-CM

Treatment with Onpattro (patisiran) for 1.5 years leads to sustained reductions in disability progression among people with ATTR amyloidosis with cardiomyopathy (ATTR-CM), or damage to the heart. That’s according to interim data from the ongoing open-label extension (OLE) portion of the Phase 3 APOLLO-B clinical trial (NCT03997383). That trial’s initial…

Continue Reading Onpattro shows benefits for 1.5 years in ATTR cardiomyopathy trial | Therapy seen to slow down disability in people with ATTR-CM

Patisiran Benefits Maintained Over 18 Months in Patients With Transthyretin Amyloidosis

The long-term extension of the phase 3 APOLLO-B study confirmed the efficacy and safety of patisiran in patients with transthyretin (ATTR) amyloidosis and highlights the importance of early treatment. Functional capacity, health status, and quality of life were preserved throughout the follow-up period. ATTR amyloidosis is a progressive and fatal…

Continue Reading Patisiran Benefits Maintained Over 18 Months in Patients With Transthyretin Amyloidosis

Alnylam Pharma Presents 18-Month Results from the APOLLO-B Phase 3 Study of Patisiran By Investing.com

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new results from an interim analysis of exploratory data from the open-label extension (OLE) period of the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy….

Continue Reading Alnylam Pharma Presents 18-Month Results from the APOLLO-B Phase 3 Study of Patisiran By Investing.com

Alnylam Presents 18-Month Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy

– Continued Treatment with Patisiran in Open-Label Extension Period Showed Evidence of Sustained Benefit across Measures of Functional Capacity and Health Status and Quality of Life, as well as Cardiac Stress and Injury, through 18 Months – – Safety Profile Consistent with that Observed in 12-Month Double-Blind Period, with No…

Continue Reading Alnylam Presents 18-Month Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy

2023-05-20 | NDAQ:ALNY | Press Release

– Continued Treatment with Patisiran in Open-Label Extension Period Showed Evidence of Sustained Benefit across Measures of Functional Capacity and Health Status and Quality of Life, as well as Cardiac Stress and Injury, through 18 Months – – Safety Profile Consistent with that Observed in 12-Month Double-Blind Period, with No…

Continue Reading 2023-05-20 | NDAQ:ALNY | Press Release

Revyve Clinic introduces cutting-edge technologies for advanced aesthetic treatments

ANI | Updated: May 16, 2023 15:12 IST Faridabad (Haryana) [India], May 16 (ANI/PNN): Revyve Clinic, the renowned center for skin and hair treatment, is set to revolutionize the aesthetic industry with the introduction of the latest and fastest technologies in the field. Dr Sandeep Babbar, the esteemed dermatologist and…

Continue Reading Revyve Clinic introduces cutting-edge technologies for advanced aesthetic treatments

Is Electrical Duodenal Resurfacing the Next Big Thing for T2D and Obesity?

CHICAGO — A novel approach to revitalizing the duodenal mucosa as a means to restore normal insulin sensitivity in people with type 2 diabetes is showing strong promise in early studies, according to results presented here. In two single-arm trials of a system called ReCET, reported at Digestive Disease Week…

Continue Reading Is Electrical Duodenal Resurfacing the Next Big Thing for T2D and Obesity?

AAN 2023: Amvuttra and Onpattro show similar efficacy as FAP treatments | Comparable, sustained drops in transthyretin levels seen

Amvuttra (vutrisiran) and Onpattro (patisiran) showed similar safety and efficacy for familial amyloid polyneuropathy (FAP) patients, according to new analyses from the Phase 3 HELIOS-A trial that supported Amvuttra’s regulatory approval. Both therapies led to similar reductions in transthyretin, the protein that accumulates in FAP, and they were associated with comparable…

Continue Reading AAN 2023: Amvuttra and Onpattro show similar efficacy as FAP treatments | Comparable, sustained drops in transthyretin levels seen

China to establish organization to coordinate international moon base

HELSINKI — China National Space Administration will soon set up an organization to oversee and coordinate the China-led International Lunar Research Station. Wu Weiren, Director General of the Deep Space Exploration Laboratory (DSEL), said during an exploration conference April 25 that the International Lunar Research Station Cooperation Organization (ILRSCO) would…

Continue Reading China to establish organization to coordinate international moon base

Genomics has enormous potential towards personalised, preventive healthcare, says Governor

Governor R.N. Ravi at the inauguration of the Apollo Genomics Institute in Chennai on Tuesday. Also seen, from left, are Sandi Deans, National Laboratory and Scientific Lead (Genomics), NHS England; Preetha Reddy, vice-chairperson, Apollo Hospitals; Prathap C. Reddy, chairman, Apollo Hospitals Group; and Suneeta Reddy, managing director, Apollo Hospitals. |…

Continue Reading Genomics has enormous potential towards personalised, preventive healthcare, says Governor

Apollo to set up more genomics institutes by 2023-end

Healthcare major Apollo Hospitals Group has drawn up plans to set up three more genomic facilities in the country, a senior official said here on Tuesday. Earlier in the day, Tamil Nadu Governor R N Ravi inaugurated the Apollo Genomic Institute in Chennai in the presence of chairman…

Continue Reading Apollo to set up more genomics institutes by 2023-end

19 Ways AI May Soon Revolutionize The Healthcare Industry

getty Technology experts are clear: Artificial intelligence is poised to revolutionize procedures and tasks across industries—and healthcare is no exception. While it’s not anticipated that AI can ever replace human doctors’ intelligence, empathy and reasoning, tech experts say it can provide invaluable assistance in a variety of health applications. From…

Continue Reading 19 Ways AI May Soon Revolutionize The Healthcare Industry

Checklist from last Apollo lunar mission sells for almost US$800,000

A piece of space history has sold at auction for US$744,994 after the moondust-besmirched checklist Apollo 17 Commander Gene Cernan wore on his spacesuited wrist during the last crewed lunar mission went on the block at RR Auctions. Previously sold in 2021, the checklist was worn by Cernan on the…

Continue Reading Checklist from last Apollo lunar mission sells for almost US$800,000

Merck acquires Prometheus Biosciences in $10.8bn deal

Prometheus’ lead candidate, PRA023, is a humanized monoclonal antibody (mAb) being development to treat immune-mediated diseases including ulcerative colitis (UC) and Crohn’s disease (CD). Founded in 1995, the company also has a second candidate in Phase 1 trials and three others in pre-clinical development. Phase 3 trials planned Merck, known…

Continue Reading Merck acquires Prometheus Biosciences in $10.8bn deal

Amazon Has Bad News for Workers Everywhere (Not Just Amazon Employees)

Just since you do not work for Amazon does not imply this main change will not make your life worse. Before the covid pandemic, unemployment hovered round all-time lows which compelled firms to make worker-friendly concessions. That’s if you noticed retailers like Walmart (WMT) – Get Free Report and Target…

Continue Reading Amazon Has Bad News for Workers Everywhere (Not Just Amazon Employees)

How the Human Genome Project revolutionised biology

Big is beautiful. That was the message of post-second-world-war science. The model was the Manhattan Project, to build the first atom bombs. When hostilities ended, it continued with larger and larger particle accelerators, to probe matter at smaller and smaller scales—and bigger telescopes to do that probing at the largest…

Continue Reading How the Human Genome Project revolutionised biology

Inside the (Deep) Mind of Demis Hassabis

He wrote computer games at 8; became a chess prodigy at 14; created Theme Park, one of the first video games to incorporate AI, at 17; took a double first in computer science from Cambridge at 20; founded a groundbreaking video-game company at 22. Who, but Demis Hassabis, could have…

Continue Reading Inside the (Deep) Mind of Demis Hassabis

Dangerous plant fungus infects man in first-known global case, doctors say

article Sabouraud dextrose agar showed growth of creamy pasty colony with buff coloured pigmentation on reverse side after 4–5 days. (Soma Dutta, Ujjwayini Ray) A man in India stumped doctors after his throat sores became documented as the world’s first case of a potentially deadly fungal infection caused by plants….

Continue Reading Dangerous plant fungus infects man in first-known global case, doctors say

Silence Therapeutics Stock: A Speculative Buy (NASDAQ:SLN)

Evgenii Kovalev Background Silence Therapeutics (NASDAQ:SLN) is a UK-based biotechnology company specializing in RNA interference [RNAi] technology. The company is focused on developing and commercializing a pipeline of therapies using its proprietary platform technology to target and silence disease-causing genes. Silence Therapeutics has a diversified pipeline of preclinical and clinical…

Continue Reading Silence Therapeutics Stock: A Speculative Buy (NASDAQ:SLN)

How Pure Storage Flash Powered Infection Disease Research

The McArthur Lab at McMaster University is a different kind of frontline fighter. The research facility fights to save lives by sequencing genomes and pathogens and studying massive datasets. Over the years, the lab has developed the world’s largest database of data related to drug-resistant infections. McArthur Lab’s genomic datasets…

Continue Reading How Pure Storage Flash Powered Infection Disease Research

Leveraging Early Cancer Detection Tech

Cancer is fast turning into an ‘epidemic’ and is the second leading cause of death globally. As per the Globocan Report of 2020, the annual global burden of cancer in 2020 in the country had hit the 1.93 crore mark with an annual death of 1 crore. Let’s explore some…

Continue Reading Leveraging Early Cancer Detection Tech

a “once in a lifetime opportunity” in 2023

Investments banks may be cutting pay and jettisoning humans in 2023, but not all financial services jobs are shrinking. Speaking at the London School of Economics’ (LSE) Alternative Investments Conference, investors working in private credit said their area of the market is in its element. Charlotte Muellers, co-head of North America…

Continue Reading a “once in a lifetime opportunity” in 2023

24 groundbreaking events that happened during the Queen’s reign

When Queen Elizabeth was crowned in 1953, she promised to rule for her whole life. It was a commitment that never waivered and saw her on the throne for more than 70 years, over which time the world changed significantly. During her reign, the Queen saw some of the most…

Continue Reading 24 groundbreaking events that happened during the Queen’s reign

Most advanced professional Aesthetic Medical Devices

WEERO is a global manufacturer to provide most advanced and the newest aesthetic medical device and beauty device to the world. The company name of WEERO means warm and upward.  WEERO is continuing to research and develop the most cutting edge technologies to stay ahead of the market, and always…

Continue Reading Most advanced professional Aesthetic Medical Devices

NIPT Testing For Pregnant Women

By Dr Niranjan Nayak, Consultant pathologist zonal technical chief west, Apollo diagnostic Pune Are you aware? Non-invasive Prenatal Testing (NIPT) means a screening test that can be done commonly in the first 3 months of pregnancy to detect chromosomal abnormalities in the baby. This test detects the 3 commonly occuring…

Continue Reading NIPT Testing For Pregnant Women

Joey Holder | Apollo 40 Under 40 Art & Tech | In Focus

London and Nottingham For her first solo show at Seventeen Gallery in London, which took place this past spring, Joey Holder immersed visitors in an eerie virtual world in which H.R. Giger-esque computer-generated creatures wriggle and writhe – a seemingly extraterrestrial landscape, lit in cool blues and greens and soundtracked…

Continue Reading Joey Holder | Apollo 40 Under 40 Art & Tech | In Focus

Colossal launches with $15 million to bring back woolly mammoths

Harvard scientist George Church, a pioneer of both DNA sequencing and gene editing, has been talking in the press for more than a decade about the possibility of bringing the extinct woolly mammoth back to life. It’s been the subject of magazine articles, books, and, of course, a TEDx talk….

Continue Reading Colossal launches with $15 million to bring back woolly mammoths

Eukaryotic Annotation Team Leader job with EMBL

We are seeking a faculty-level genome scientist to lead the Eukaryotic Annotation Team at the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI).  As Team Leader you will have strategic responsibility for gene annotation and comparative genomics in the Ensembl project, and also lead the EMBL contribution to a portfolio…

Continue Reading Eukaryotic Annotation Team Leader job with EMBL